High plasma IL-6 levels may enhance the adverse effects of mouse allergen exposure in urban schools on asthma morbidity in children
Few data on the relationships between environmental exposures, asthma morbidity, and systemic IL-6 inflammation exist. We sought to determine whether baseline plasma IL-6 level is associated with increased asthma morbidity in children exposed to mouse allergen in inner-city classrooms. Data from the...
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 2023-12, Vol.152 (6), p.1677-1682 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1682 |
---|---|
container_issue | 6 |
container_start_page | 1677 |
container_title | Journal of allergy and clinical immunology |
container_volume | 152 |
creator | Akar-Ghibril, Nicole Greco, Kimberly F Jackson-Browne, Medina Phipatanakul, Wanda Permaul, Perdita |
description | Few data on the relationships between environmental exposures, asthma morbidity, and systemic IL-6 inflammation exist.
We sought to determine whether baseline plasma IL-6 level is associated with increased asthma morbidity in children exposed to mouse allergen in inner-city classrooms.
Data from the longitudinal School Inner-City Asthma Studies of 215 children with asthma, aged 4 to 14 years and recruited from urban elementary schools, were analyzed. Given the unknown threshold of IL-6 risk levels and skewness of the distribution, the children were stratified into tertiles as follows: low baseline IL-6 level (0.302 pg/mL). Relationships between plasma IL-6 level and body mass index (BMI) percentile, inflammatory markers, lung function, mouse allergen exposure, and asthma outcomes were assessed.
Cross-sectional analysis demonstrated that increasing IL-6 level was associated with higher BMI percentile (P < .0001), C-reactive protein level (P = .0006), and blood neutrophil count (P = .0024). IL-6 was not associated with type 2 inflammatory markers, including blood eosinophil count, allergic sensitization, or fractional exhaled nitric oxide level. Longitudinal analysis showed that children with high IL-6 levels had a higher number of days with asthma symptoms than did those children with moderate (incidence rate ratio = 1.74 [95% CI = 1.10-2.77]; P = .0187) or low (incidence rate ratio =1.83 [95% CI = 1.21-2.77]; P = .0043) IL-6 levels. Children with high IL-6 levels who were exposed to increasing levels of mouse allergen exhibited lower ratios of FEV
value to forced vital capacity than did children with moderate IL-6 levels (β = -0.0044 [95% CI = -0.0073 to -0.0015]; pairwise interaction P = .0028) or low IL-6 levels (β = -0.0042 [95% CI = - 0.0070 to -0.0013]; pairwise interaction P = .0039).
Inner-city children with asthma and high plasma IL-6 levels are more likely to have an increased BMI, elevated C-reactive protein level, elevated blood neutrophil count, and greater asthma symptoms. High IL-6 level appears to increase susceptibility to the effects of classroom exposure to mouse allergen on lung function in urban children. |
doi_str_mv | 10.1016/j.jaci.2023.06.027 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10837306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2846926675</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-f65e085a6e80c0b16f3030293c3db5e86140090e5dc1c05a938e4b79607f85293</originalsourceid><addsrcrecordid>eNpVkU9v3CAQxVHVqtmm_QI9VBx7sTsYg-1TVUXNH2mlXNIzwni8ZoVhC_aqe84XL6ukUXpCMG_em-FHyGcGJQMmv-3LvTa2rKDiJcgSquYN2TDomkK2lXhLNgAdK2RTdxfkQ0p7yHfedu_JBW9Ezeq225DHW7ub6MHpNGt6ty0kdXhEl-isTxT9pL1BukxI9XDEmJDiOKJZEg0jncOaH7RzGHfoKf45hLRGpNbTNfba02SmELJX8FSnZcoJc4i9HexyOovMZN0Q0X8k70btEn56Pi_Jr-ufD1e3xfb-5u7qx7YwXHRLMUqB0AotsQUDPZMjBw5Vxw0feoGtZHVeEFAMhhkQOu-Kdd90EpqxFVl3Sb4_-R7WfsbBoF-iduoQ7azjSQVt1f8Vbye1C0fFoOUNB5kdvj47xPB7xbSo2SaDzmmP-TNU1dayq6RsRJZWT1ITQ0oRx5ccBuqMT-3VGZ8641MgVcaXm768nvCl5R8v_hcBQJlP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2846926675</pqid></control><display><type>article</type><title>High plasma IL-6 levels may enhance the adverse effects of mouse allergen exposure in urban schools on asthma morbidity in children</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Akar-Ghibril, Nicole ; Greco, Kimberly F ; Jackson-Browne, Medina ; Phipatanakul, Wanda ; Permaul, Perdita</creator><creatorcontrib>Akar-Ghibril, Nicole ; Greco, Kimberly F ; Jackson-Browne, Medina ; Phipatanakul, Wanda ; Permaul, Perdita</creatorcontrib><description>Few data on the relationships between environmental exposures, asthma morbidity, and systemic IL-6 inflammation exist.
We sought to determine whether baseline plasma IL-6 level is associated with increased asthma morbidity in children exposed to mouse allergen in inner-city classrooms.
Data from the longitudinal School Inner-City Asthma Studies of 215 children with asthma, aged 4 to 14 years and recruited from urban elementary schools, were analyzed. Given the unknown threshold of IL-6 risk levels and skewness of the distribution, the children were stratified into tertiles as follows: low baseline IL-6 level (<0.013 pg/mL), moderate baseline IL-6 level (0.013-0.302 pg/mL), and high baseline IL-6 level (>0.302 pg/mL). Relationships between plasma IL-6 level and body mass index (BMI) percentile, inflammatory markers, lung function, mouse allergen exposure, and asthma outcomes were assessed.
Cross-sectional analysis demonstrated that increasing IL-6 level was associated with higher BMI percentile (P < .0001), C-reactive protein level (P = .0006), and blood neutrophil count (P = .0024). IL-6 was not associated with type 2 inflammatory markers, including blood eosinophil count, allergic sensitization, or fractional exhaled nitric oxide level. Longitudinal analysis showed that children with high IL-6 levels had a higher number of days with asthma symptoms than did those children with moderate (incidence rate ratio = 1.74 [95% CI = 1.10-2.77]; P = .0187) or low (incidence rate ratio =1.83 [95% CI = 1.21-2.77]; P = .0043) IL-6 levels. Children with high IL-6 levels who were exposed to increasing levels of mouse allergen exhibited lower ratios of FEV
value to forced vital capacity than did children with moderate IL-6 levels (β = -0.0044 [95% CI = -0.0073 to -0.0015]; pairwise interaction P = .0028) or low IL-6 levels (β = -0.0042 [95% CI = - 0.0070 to -0.0013]; pairwise interaction P = .0039).
Inner-city children with asthma and high plasma IL-6 levels are more likely to have an increased BMI, elevated C-reactive protein level, elevated blood neutrophil count, and greater asthma symptoms. High IL-6 level appears to increase susceptibility to the effects of classroom exposure to mouse allergen on lung function in urban children.</description><identifier>ISSN: 0091-6749</identifier><identifier>ISSN: 1097-6825</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2023.06.027</identifier><identifier>PMID: 37541489</identifier><language>eng</language><publisher>United States</publisher><subject>Allergens - adverse effects ; Animals ; Asthma - etiology ; C-Reactive Protein - analysis ; Child ; Cross-Sectional Studies ; Drug-Related Side Effects and Adverse Reactions ; Environmental Exposure - adverse effects ; Environmental Exposure - analysis ; Humans ; Interleukin-6 ; Mice ; Morbidity ; Schools</subject><ispartof>Journal of allergy and clinical immunology, 2023-12, Vol.152 (6), p.1677-1682</ispartof><rights>Copyright © 2023 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-f65e085a6e80c0b16f3030293c3db5e86140090e5dc1c05a938e4b79607f85293</citedby><cites>FETCH-LOGICAL-c359t-f65e085a6e80c0b16f3030293c3db5e86140090e5dc1c05a938e4b79607f85293</cites><orcidid>0000-0002-0028-8927</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37541489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akar-Ghibril, Nicole</creatorcontrib><creatorcontrib>Greco, Kimberly F</creatorcontrib><creatorcontrib>Jackson-Browne, Medina</creatorcontrib><creatorcontrib>Phipatanakul, Wanda</creatorcontrib><creatorcontrib>Permaul, Perdita</creatorcontrib><title>High plasma IL-6 levels may enhance the adverse effects of mouse allergen exposure in urban schools on asthma morbidity in children</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Few data on the relationships between environmental exposures, asthma morbidity, and systemic IL-6 inflammation exist.
We sought to determine whether baseline plasma IL-6 level is associated with increased asthma morbidity in children exposed to mouse allergen in inner-city classrooms.
Data from the longitudinal School Inner-City Asthma Studies of 215 children with asthma, aged 4 to 14 years and recruited from urban elementary schools, were analyzed. Given the unknown threshold of IL-6 risk levels and skewness of the distribution, the children were stratified into tertiles as follows: low baseline IL-6 level (<0.013 pg/mL), moderate baseline IL-6 level (0.013-0.302 pg/mL), and high baseline IL-6 level (>0.302 pg/mL). Relationships between plasma IL-6 level and body mass index (BMI) percentile, inflammatory markers, lung function, mouse allergen exposure, and asthma outcomes were assessed.
Cross-sectional analysis demonstrated that increasing IL-6 level was associated with higher BMI percentile (P < .0001), C-reactive protein level (P = .0006), and blood neutrophil count (P = .0024). IL-6 was not associated with type 2 inflammatory markers, including blood eosinophil count, allergic sensitization, or fractional exhaled nitric oxide level. Longitudinal analysis showed that children with high IL-6 levels had a higher number of days with asthma symptoms than did those children with moderate (incidence rate ratio = 1.74 [95% CI = 1.10-2.77]; P = .0187) or low (incidence rate ratio =1.83 [95% CI = 1.21-2.77]; P = .0043) IL-6 levels. Children with high IL-6 levels who were exposed to increasing levels of mouse allergen exhibited lower ratios of FEV
value to forced vital capacity than did children with moderate IL-6 levels (β = -0.0044 [95% CI = -0.0073 to -0.0015]; pairwise interaction P = .0028) or low IL-6 levels (β = -0.0042 [95% CI = - 0.0070 to -0.0013]; pairwise interaction P = .0039).
Inner-city children with asthma and high plasma IL-6 levels are more likely to have an increased BMI, elevated C-reactive protein level, elevated blood neutrophil count, and greater asthma symptoms. High IL-6 level appears to increase susceptibility to the effects of classroom exposure to mouse allergen on lung function in urban children.</description><subject>Allergens - adverse effects</subject><subject>Animals</subject><subject>Asthma - etiology</subject><subject>C-Reactive Protein - analysis</subject><subject>Child</subject><subject>Cross-Sectional Studies</subject><subject>Drug-Related Side Effects and Adverse Reactions</subject><subject>Environmental Exposure - adverse effects</subject><subject>Environmental Exposure - analysis</subject><subject>Humans</subject><subject>Interleukin-6</subject><subject>Mice</subject><subject>Morbidity</subject><subject>Schools</subject><issn>0091-6749</issn><issn>1097-6825</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU9v3CAQxVHVqtmm_QI9VBx7sTsYg-1TVUXNH2mlXNIzwni8ZoVhC_aqe84XL6ukUXpCMG_em-FHyGcGJQMmv-3LvTa2rKDiJcgSquYN2TDomkK2lXhLNgAdK2RTdxfkQ0p7yHfedu_JBW9Ezeq225DHW7ub6MHpNGt6ty0kdXhEl-isTxT9pL1BukxI9XDEmJDiOKJZEg0jncOaH7RzGHfoKf45hLRGpNbTNfba02SmELJX8FSnZcoJc4i9HexyOovMZN0Q0X8k70btEn56Pi_Jr-ufD1e3xfb-5u7qx7YwXHRLMUqB0AotsQUDPZMjBw5Vxw0feoGtZHVeEFAMhhkQOu-Kdd90EpqxFVl3Sb4_-R7WfsbBoF-iduoQ7azjSQVt1f8Vbye1C0fFoOUNB5kdvj47xPB7xbSo2SaDzmmP-TNU1dayq6RsRJZWT1ITQ0oRx5ccBuqMT-3VGZ8641MgVcaXm768nvCl5R8v_hcBQJlP</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Akar-Ghibril, Nicole</creator><creator>Greco, Kimberly F</creator><creator>Jackson-Browne, Medina</creator><creator>Phipatanakul, Wanda</creator><creator>Permaul, Perdita</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0028-8927</orcidid></search><sort><creationdate>20231201</creationdate><title>High plasma IL-6 levels may enhance the adverse effects of mouse allergen exposure in urban schools on asthma morbidity in children</title><author>Akar-Ghibril, Nicole ; Greco, Kimberly F ; Jackson-Browne, Medina ; Phipatanakul, Wanda ; Permaul, Perdita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-f65e085a6e80c0b16f3030293c3db5e86140090e5dc1c05a938e4b79607f85293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Allergens - adverse effects</topic><topic>Animals</topic><topic>Asthma - etiology</topic><topic>C-Reactive Protein - analysis</topic><topic>Child</topic><topic>Cross-Sectional Studies</topic><topic>Drug-Related Side Effects and Adverse Reactions</topic><topic>Environmental Exposure - adverse effects</topic><topic>Environmental Exposure - analysis</topic><topic>Humans</topic><topic>Interleukin-6</topic><topic>Mice</topic><topic>Morbidity</topic><topic>Schools</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akar-Ghibril, Nicole</creatorcontrib><creatorcontrib>Greco, Kimberly F</creatorcontrib><creatorcontrib>Jackson-Browne, Medina</creatorcontrib><creatorcontrib>Phipatanakul, Wanda</creatorcontrib><creatorcontrib>Permaul, Perdita</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akar-Ghibril, Nicole</au><au>Greco, Kimberly F</au><au>Jackson-Browne, Medina</au><au>Phipatanakul, Wanda</au><au>Permaul, Perdita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High plasma IL-6 levels may enhance the adverse effects of mouse allergen exposure in urban schools on asthma morbidity in children</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>152</volume><issue>6</issue><spage>1677</spage><epage>1682</epage><pages>1677-1682</pages><issn>0091-6749</issn><issn>1097-6825</issn><eissn>1097-6825</eissn><abstract>Few data on the relationships between environmental exposures, asthma morbidity, and systemic IL-6 inflammation exist.
We sought to determine whether baseline plasma IL-6 level is associated with increased asthma morbidity in children exposed to mouse allergen in inner-city classrooms.
Data from the longitudinal School Inner-City Asthma Studies of 215 children with asthma, aged 4 to 14 years and recruited from urban elementary schools, were analyzed. Given the unknown threshold of IL-6 risk levels and skewness of the distribution, the children were stratified into tertiles as follows: low baseline IL-6 level (<0.013 pg/mL), moderate baseline IL-6 level (0.013-0.302 pg/mL), and high baseline IL-6 level (>0.302 pg/mL). Relationships between plasma IL-6 level and body mass index (BMI) percentile, inflammatory markers, lung function, mouse allergen exposure, and asthma outcomes were assessed.
Cross-sectional analysis demonstrated that increasing IL-6 level was associated with higher BMI percentile (P < .0001), C-reactive protein level (P = .0006), and blood neutrophil count (P = .0024). IL-6 was not associated with type 2 inflammatory markers, including blood eosinophil count, allergic sensitization, or fractional exhaled nitric oxide level. Longitudinal analysis showed that children with high IL-6 levels had a higher number of days with asthma symptoms than did those children with moderate (incidence rate ratio = 1.74 [95% CI = 1.10-2.77]; P = .0187) or low (incidence rate ratio =1.83 [95% CI = 1.21-2.77]; P = .0043) IL-6 levels. Children with high IL-6 levels who were exposed to increasing levels of mouse allergen exhibited lower ratios of FEV
value to forced vital capacity than did children with moderate IL-6 levels (β = -0.0044 [95% CI = -0.0073 to -0.0015]; pairwise interaction P = .0028) or low IL-6 levels (β = -0.0042 [95% CI = - 0.0070 to -0.0013]; pairwise interaction P = .0039).
Inner-city children with asthma and high plasma IL-6 levels are more likely to have an increased BMI, elevated C-reactive protein level, elevated blood neutrophil count, and greater asthma symptoms. High IL-6 level appears to increase susceptibility to the effects of classroom exposure to mouse allergen on lung function in urban children.</abstract><cop>United States</cop><pmid>37541489</pmid><doi>10.1016/j.jaci.2023.06.027</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0028-8927</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-6749 |
ispartof | Journal of allergy and clinical immunology, 2023-12, Vol.152 (6), p.1677-1682 |
issn | 0091-6749 1097-6825 1097-6825 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10837306 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Allergens - adverse effects Animals Asthma - etiology C-Reactive Protein - analysis Child Cross-Sectional Studies Drug-Related Side Effects and Adverse Reactions Environmental Exposure - adverse effects Environmental Exposure - analysis Humans Interleukin-6 Mice Morbidity Schools |
title | High plasma IL-6 levels may enhance the adverse effects of mouse allergen exposure in urban schools on asthma morbidity in children |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A42%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20plasma%20IL-6%20levels%20may%20enhance%20the%20adverse%20effects%20of%20mouse%20allergen%20exposure%20in%20urban%20schools%20on%20asthma%20morbidity%20in%20children&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Akar-Ghibril,%20Nicole&rft.date=2023-12-01&rft.volume=152&rft.issue=6&rft.spage=1677&rft.epage=1682&rft.pages=1677-1682&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2023.06.027&rft_dat=%3Cproquest_pubme%3E2846926675%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2846926675&rft_id=info:pmid/37541489&rfr_iscdi=true |